Dual farnesoid X receptor/TGR5 agonist INT‐767 reduces liver injury in the Mdr2−/− (Abcb4−/−) mouse cholangiopathy model by promoting biliary HCO 3− output
暂无分享,去创建一个
A. Baghdasaryan | M. Trauner | M. Strazzabosco | L. Adorini | K. Schoonjans | A. Roda | J. Gumhold | P. Fickert | F. Gonzalez | D. Silbert | T. Claudel | S. Vecchiotti